1,100
Participants
Start Date
July 9, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Blood draw
Before undergoing a prostate biopsy, participants will have about 10 mLs of venous blood drawn. Blood will be sent to Geneseeq Technology Inc. for whole genome high-throughput sequencing of plasma cfDNA.
RECRUITING
Changzheng hospital, Shanghai
Ningbo No. 1 Hospital
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Jiangsu Provincial People's Hospital
OTHER
The First Affiliated Hospital of Soochow University
OTHER
West China Hospital
OTHER
Zhongda Hospital
OTHER
Northern Jiangsu People's Hospital
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Shanghai Changzheng Hospital
OTHER